Lords Mark Industries Ltd. Achieves US FDA Registration, Strengthening India’s Global Healthcare Manufacturing Leadership

Lynn Martelli
Lynn Martelli

Lords Mark Industries Ltd. has officially obtained registration from the US Food and Drug Administration (US FDA) for its comprehensive range of surgical consumables, orthopedic supports, and hygiene solutions. This landmark achievement highlights the company’s manufacturing excellence and reinforces India’s growing influence in the global healthcare ecosystem.

The US FDA registration represents one of the most stringent benchmarks for product safety, quality assurance, and regulatory compliance. For Indian manufacturers, this certification serves as a gateway to highly regulated international markets, including the United States, the European Union, and the Middle East — unlocking vast opportunities for expansion. For Lords Mark Industries, it marks a defining step in its global growth trajectory, enhancing export potential and supporting India’s vision of becoming an international hub for healthcare manufacturing.

Extensive FDA-Approved Portfolio

The company’s FDA-approved portfolio spans multiple healthcare categories, covering medical consumables such as Cotton Crepe Bandages, Elastic Adhesive Bandages, Cannula Fixators, and Disinfectant Wet Wipes. It also includes rehabilitation and orthopedic aids like abdominal and rib belts, lumbar supports, cervical collars, Taylor’s braces, arm slings, shoulder immobilizers, cockup splints, and knee immobilizers. Complementing these offerings, the Lord’s Joy brand delivers a hygiene range that includes baby wipes, bed bath wipes, and refreshing wipes.

State-of-the-Art Manufacturing Infrastructure

At the core of this achievement lies Lords Mark Industries Ltd.’s advanced surgical manufacturing facility in Dadra & Nagar Haveli. The unit houses five integrated divisions and employs more than 100 skilled professionals, combining precision engineering with superior production capabilities.

The plant operates under the 5S manufacturing discipline to ensure efficiency and organization, supported by a robust QC/QA framework featuring multiple layers of inspection, testing, and validation. Its infrastructure includes five loom machines, TFO and cheese winders, warping and dyeing units, 38 stitching machines, and a fully automated elastic adhesive coating line.

This facility adheres to the highest global quality standards, maintaining certifications under ISO 13485:2016, WHO-GMP, CDSCO, cGMP, GLP, Indian FDA, and US FDA norms — ensuring each product meets international expectations for safety, consistency, and performance.

Innovative Logistics and Quality Excellence Framework

Beyond manufacturing, Lords Mark Industries has modernized its logistics operations through digital integration and real-time tracking, guaranteeing precision delivery for both domestic and global shipments. Its predictive logistics framework leverages data analytics to optimize routes, enhance packaging traceability, and accelerate turnaround times — minimizing delays and reducing operational costs while ensuring dependable, on-schedule delivery.

The organization’s six-step Quality Excellence Framework further reinforces operational discipline across specification setting, stage-wise testing, staff training, performance tracking, corrective measures, and continuous improvement. Every employee is trained to embody this quality-first culture — ensuring that the company’s motto, “Hamesha Aapke Saath,” remains a living principle in day-to-day operations.

Leadership Vision

Speaking on the company’s milestone, Mr. Sachidanand Upadhyay, Managing Director of Lords Mark Industries Ltd., stated:

“Our mission is to make India a global source of world-class, affordable healthcare solutions. US FDA registration empowers us to deliver on this vision and expand our footprint across key international markets.”

Under the guidance of Mr. Manav Teli, Executive Director, and Mr. Niraj Oza, Business Head, the company has scaled its operations with a strong focus on automation, R&D-driven innovation, and sustainability.

Commenting on the achievement, Mr. Manav Teli added:

“US FDA registration confirms our focus on quality and innovation. Through automation, rigorous QC processes, and advanced logistics, we are shaping a global healthcare supply chain that is efficient, transparent, and technology-led.”

A Step Toward Global Leadership

With this registration, Lords Mark Industries Ltd. — which already operates its US subsidiary, Lords Mark Global LLC in Texas — joins the elite group of Indian healthcare manufacturers with FDA recognition, alongside renowned companies such as Sun Pharma, Cipla, Dr. Reddy’s, Biocon, Meril Life Sciences, and Poly Medicure.

The company’s US presence strengthens its vision of promoting India’s manufacturing capabilities while strategically expanding across North American and allied markets. Today, India hosts over 700 FDA-registered facilities, underscoring its global leadership in the production of compliant, affordable, and high-quality healthcare.

Share This Article